Chest
Volume 112, Issue 5, November 1997, Pages 1154-1158
EditorialsHost Defense Response and Outcome in ARDS
REFERENCES (52)
- et al.
The acute phase response
Immunol Today
(1994) - et al.
Cytokine networks in the regulation of inflammation and fibrosis in the lung
Chest
(1990) - et al.
Cytokines and the hypothalamic-pituitary-adrenal axis
J Steroid Biochem Mol Biol
(1990) - et al.
Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 are consistent and efficient predictors of outcome over time
Chest
(1995) - et al.
Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts poor outcome
Chest
(1995) - et al.
Total respiratory pressure-volume curves in the adult respiratory distress syndrome
Chest
(1984) - et al.
An early test of survival in patients with the adult respiratory distress syndrome: the PaO2/Fio2 ratio and its response to conventional therapy: Prostaglandin El Study Group
Chest
(1989) - et al.
Infections and the inflammatory response in acute respiratory distress syndrome
Chest
(1997) - et al.
Adult respiratory distress syndrome: sequence and importance of development of multiple organ failure: The Prostaglandin El Study Group
Chest
(1992) - et al.
Systemic phospholipase A2 and cachectin levels in adult respiratory distress syndrome and multiple-organ failure
Clin Biochem
(1992)
Pulmonary endothelial permeability in patients with severe lung injury
Chest
(1994)
Clinical predictors of prolonged translaryngeal intubation in patients with the adult respiratory distress syndrome
Chest
(1990)
Evaluation of the progress and prognosis of adult respiratory distress syndrome: simple respiratory physiologic measurement
Chest
(1979)
Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-l/EPA)
J Biol Chem
(1991)
Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS
Chest
(1995)
The role of the host defense response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment
Eur Respir J
(1996)
Type III procollagen peptide in the adult respiratory distress syndrome: association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death
Ann Intern Med
(1995)
Type III procollagen peptide is present in pulmonary edema fluid on day one in patients with acute respiratory distress syndrome (ARDS) [abstract]
Am J Respir Crit Care Med
(1996)
Pulmonary fibroblast function in an acute lung injury model
J Trauma
(1995)
Activation of coagulation after administration of tumor necrosis factor to normal subjects
N Engl J Med
(1990)
Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo
Endocrinology
(1993)
Correlation among inflammatory cytokines in patients with ARDS [abstract]
Chest
(1993)
Nuclear factor-KB is activated in alveolar macrophages from patients with acute respiratory distress syndrome
Crit Care Med
(1996)
The fibroproliferative phase of late adult respiratory distress syndrome
Semin Respir Infect
(1995)
The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage
Am J Pathol
(1987)
Effects of PEEP on pulmonary mechanics and oxygen transport in the late stages of acute pulmonary failure
Inten Care Med
(1981)
Cited by (26)
Prolonged glucocorticoid treatment in ARDS: Pathobiological rationale and pharmacological principles
2023, Stress: Immunology and Inflammation: Handbook of Stress Series Volume 5Cytokine Release
2008, Mechanical Ventilation: Clinical Applications and PathophysiologyGI complications in patients receiving mechanical ventilation
2001, ChestCitation Excerpt :If these processes are not attenuated, excessive amplification of the inflammatory cascade and overproduction of proinflammatory mediators can occur with the consequent uncontrolled activation of the immune system.21,22 These processes can lead to a number of clinical sequelae in the GI tract as a part of multiple organ dysfunction syndrome (MODS).23,24 Cytokines may contribute to splanchnic hypoperfusion as well, and may also impair intestinal smooth muscle function.16,25,26,27
Professor of Medicine, University of Tennessee.
Copyright © 1997 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.